These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6129559)

  • 1. Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient.
    Zaroslinski J; Borgman RJ; O'Donnell JP; Anderson WG; Erhardt PW; Kam ST; Reynolds RD; Lee RJ; Gorczynski RJ
    Life Sci; 1982 Aug; 31(9):899-907. PubMed ID: 6129559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
    Gray RJ
    Chest; 1988 Feb; 93(2):398-403. PubMed ID: 2892647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
    Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
    Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonthrombolytic intervention in acute myocardial infarction.
    Kirshenbaum JM
    Am J Cardiol; 1989 Jul; 64(4):25B-28B. PubMed ID: 2568748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic pharmacology of esmolol.
    Gorczynski RJ
    Am J Cardiol; 1985 Oct; 56(11):3F-13F. PubMed ID: 2864846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
    Viray R; Turlapaty P; Laddu A
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):153-61. PubMed ID: 2900818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
    Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
    Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmolol in acute ischemic syndromes.
    Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
    Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of talinolol, a beta 1-selective beta blocker, in cardiac arrhythmia and acute myocardial infarction.
    Assmann I
    Curr Med Res Opin; 1995; 13(6):325-42. PubMed ID: 8829891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction.
    Braunwald E; Muller JE; Kloner RA; Maroko PR
    Am J Med; 1983 Jan; 74(1):113-23. PubMed ID: 6129798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative use of esmolol.
    Reves JG; Flezzani P
    Am J Cardiol; 1985 Oct; 56(11):57F-62F. PubMed ID: 2864850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
    Kloner RA; Kirshenbaum J; Lange R; Antman EM; Braunwald E
    Am J Cardiol; 1985 Oct; 56(11):40F-48F. PubMed ID: 2864848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.
    Balcells J; Rodríguez M; Pujol M; Iglesias J
    Pediatr Cardiol; 2004; 25(2):160-2. PubMed ID: 15046104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a new beta-blocking drug (SP/1601) on the extension of experimental acute infarct in anesthetized dogs].
    Merlo L; Brusoni B; Marchetti G
    Boll Soc Ital Cardiol; 1977; 22(7):1048-52. PubMed ID: 36114
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
    Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
    Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockade as an alternative to cardioplegic arrest during cardiopulmonary bypass.
    Warters RD; Allen SJ; Davis KL; Geissler HJ; Bischoff I; Mutschler E; Mehlhorn U
    Ann Thorac Surg; 1998 Apr; 65(4):961-6. PubMed ID: 9564910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
    Poveda-Jaramillo R; Monaco F; Zangrillo A; Landoni G
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1415-1425. PubMed ID: 29398384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.